|
Novel Materials for Viral Purification
|
1R43CA217454-01A1
|
$224,166
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Preparation of site-specific antibody-drug conjugates by proximity-based sortase ligation
|
1R41CA221374-01
|
$224,996
|
|
TSOURKAS, ANDREW
|
ALPHATHERA, INC.
|
|
Tenth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA221309-01
|
$66,000
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-31
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
MSI Faculty in the Field of Cancer Research
|
5R13CA076526-20
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Breakthrough sub-cellular 3D chemical composition research platform for live cells, based on the new invention of nanoscale - confocal photothermal IR micro-spectroscopy (n-CPIR)
|
1R41CA224844-01
|
$225,000
|
|
CHENG, JI-XIN
|
ANASYS INSTRUMENTS CORPORATION
|
|
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
|
2R44CA189522-02
|
$1,091,279
|
|
LEVENE, MICHAEL
|
APPLIKATE TECHNOLOGIES, LLC
|
|
Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence
|
1R21CA220150-01
|
$123,600
|
|
JOHNSTON, STEPHEN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
|
3R01CA197902-03S1
|
$100,000
|
|
TASEVSKA, NATASHA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Proteasome inhibitors for the treatment of solid tumors
|
1R01CA213223-01A1
|
$381,450
|
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
$24,361
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-14
|
$307,800
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
PTEN, Tregs and MDSCs in the tumor microenvironment
|
1R01CA211229-01A1
|
$347,700
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
Dynamic effects of cancer mutations on the mammalian SWI/SNF ATPase Brg
|
4R00CA187565-03
|
$249,000
|
|
HODGES, HAMILTON
|
BAYLOR COLLEGE OF MEDICINE
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
1F99CA222736-01
|
$45,544
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
1F32CA221015-01
|
$56,694
|
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer
|
1R21CA213535-01A1
|
$185,933
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
|
1R01CA212119-01A1
|
$580,951
|
|
CHEN, YUAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia
|
4R00CA197498-04
|
$249,000
|
|
CHEN, CHUN-WEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
5UH2CA213385-02
|
$49,295
|
$49,295
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
FEN1-mediated Okazaki fragment maturation and its deficiency in cancer
|
2R01CA073764-21
|
$369,788
|
|
SHEN, BINGHUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the
|
1R01CA212605-01A1
|
$536,535
|
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Determining the role of DNMT-interacting RNAs in myeloid disorders
|
4R00CA188595-03
|
$249,000
|
|
DI RUSCIO, ANNALISA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulatory role of long noncoding RNAs in normal and cancer cells
|
1R50CA211304-01A1
|
$261,280
|
|
EBRALIDZE, ALEXANDER
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-07
|
$465,791
|
$465,791
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
|
1K01CA222707-01
|
$114,242
|
|
TRINH, BON
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
|
1R43CA224512-01
|
$299,340
|
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
Role of Insulin Receptor Substrates in Kras-driven lung cancer
|
1R01CA211944-01A1
|
$404,888
|
|
KALAANY, NADA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cooperation of Hippo/Yap and Hedgehog Pathways in BCC Development
|
3F32CA192815-02S1
|
$316
|
|
MAGLIC, DEJAN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Epigenetic regulation of cellular plasticity and cancer cell fate
|
1R35CA210104-01A1
|
$753,725
|
|
SHI, YANG
|
BOSTON CHILDREN'S HOSPITAL
|
|
Mammographic density and breast cancer risk in African American women
|
1R01CA214542-01A1
|
$477,552
|
|
BERTRAND, KIMBERLY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
An interactive analysis toolkit for single cell RNA-seq in cancer research
|
1U01CA220413-01
|
$397,988
|
|
JOHNSON, WILLIAM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Targeting Transcriptional Co-repressor CoREST Complex in Melanoma
|
1R01CA212639-01A1
|
$369,038
|
|
RYU, BYUNGWOO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
|
R01AR070234-02S1
|
$55,691
|
|
Anandasabapathy, Niroshana
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
$262,200
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
3U24CA180918-05S1
|
$254,713
|
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Role of melanoma-PD-1 in cancer progression
|
1R01CA190838-01A1
|
$395,502
|
|
SCHATTON, TOBIAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In vivo imaging of the stem cell loaded oncolytic viruses for cancer therapy
|
7R01CA204720-02
|
$406,031
|
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Global Infrastructure for Collaborative High-throughput
|
3U24CA210999-02S1
|
$50,847
|
|
GETZ, GAD
|
BROAD INSTITUTE, INC.
|
|
De-repression of tumor suppressor genes by DNA-binding polyamides at hypermethylated CpG promoters
|
1F32CA213962-01A1
|
$56,694
|
|
FINN, PAUL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Optimization of a novel cancer immunotherapeutic antibody for human use
|
3R41CA206688-01A1S1
|
$50,000
|
|
WU, JENNIFER
|
CANCURE, LLC
|
|
Case CCC Youth Engaged in Science
|
1R25CA221718-01
|
$486,000
|
|
BERGER, NATHAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Nuclear Factor I/B Action in Castrate Resistant Prostate Cancer
|
4R00CA197315-04
|
$249,000
|
|
GRABOWSKA, MAGDALENA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Elucidating and Leveraging the mTOR Negative Feedback Pathway in Breast Cancer
|
1R01CA213843-01A1
|
$408,250
|
|
KERI, RUTH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Impact of the Microbiome on the Efficacy of Radiation Therapy
|
1R01CA220000-01
|
$350,000
|
|
SHIAO, STEPHEN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
|
1R44CA221624-01
|
$999,038
|
|
Levi, Jelena
|
CELLSIGHT TECHNOLOGIES, INC.
|
|
Deciphering the coupled roles of protein secretion and metabolism in cancer using an integrative omics approach
|
1F32CA220848-01
|
$52,716
|
|
ROBINSON, JONATHAN
|
CHALMERS UNIVERSITY OF TECHNOLOGY
|
|
Deciphering the coupled roles of protein secretion and metabolism in cancer using
|
1F32CA220848-01X1
|
$4,200
|
|
Robinson
|
CHALMERS UNIVERSITY OF TECHNOLOGY
|
|
The role of H3K79 methylation in IDH-mutant leukemia
|
7R01CA201230-03
|
$428,638
|
|
BERNT, KATHRIN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
U2C Kids First Admin Supplement - cloud-based data storage and compute
|
U2CHL138346-01S2
|
$1,800,000
|
|
Resnick, Adam
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $16,724,748
|